Posts

COVID vaccine works faster with both doses in the same arm

Nature, Published online: 29 April 2025; doi:10.1038/d41586-025-01326-2Quick imm...

Webinar: How Fintech Can Accelerate Growth for Early-St...

[Sponsored] Sign up today and and join us on May 8th where we’ll explore how a b...

Hims and Novo Nordisk partner to offer discounted Wegovy

In an unlikely partnership between two rivals, Hims & Hers said its members will...

AstraZeneca, Novartis execute ‘US for US’ strategy as p...

With the industry on tenterhooks on what the pharma-specific tariffs may look li...

Brand-new Falcon 9 rocket sends 23 Starlink satellites ...

SpaceX sent another batch of Starlink satellites to orbit tonight (April 28), it...

Pfizer plans more cost cuts, expanding total savings to...

Pfizer is expanding its multibillion-dollar cost-cutting effort that began in 20...

If HPV Infection Increases Heart Disease Risk, Can Vacc...

A vaccine that blocks infection with the human papillomavirus has helped to lowe...

Basil Systems raises $11.5M to help pharma navigate reg...

A startup built to help pharmaceutical and medical device companies make sense o...

Before you travel, make sure you do this to avoid roami...

This e-SIM comes with a $50 credit to purchase data plans around the world. The ...

Why Psytec Games Made Titan Isles Over Windlands 3

With co-op action title Titan Isles launching this year, we interviewed Psytec G...

Will US science survive Trump 2.0?

Nature, Published online: 29 April 2025; doi:10.1038/d41586-025-01295-6President...

AstraZeneca posts another Truqap study fail, says China...

AstraZeneca’s Truqap is 2-for-4 in its pivotal cancer trials. It said it was shu...

5 Ways Trump Administration Tariffs Are Impacting U.S. ...

What You Should Know:  – Recent changes to U.S. trade policy under the Trump Adm...

IMF raises US recession risk as tariffs drive global ec...

Top finance news: IMF ramps up probability of a US recession; Emerging markets s...

Novartis Q1 earnings: Company raises 2025 success bar a...

Novartis is starting the year on a strong note as several of its core medicines ...

In the Starlight: Jason Phillips’ Unexpected Path to Jo...

Sometimes an unexpected turn in a carefully planned career path leads to surpris...

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.